Immuno-Oncology Center Cologne

9.90

Cologne, Germany

User Score	Total Reviews	Rating	Price Range	Media Files	Certificates	Founded In	Patients	Departments	Ownership	Clinical trials	Age Group	Clinic Type	Type of Care	Size	Online Consultations
99%	22	9.9/10	$$$$	38	2	1985	350	1 medical unit	Private hospital	Conduct clinical trials	Kids, Adults	Specialized	Outpatient	Small	Yes

Overview

Size

Small

Clinic type

Specialized

Type of care

Outpatient

Age group

Kids, Adults

4.0 on Google

The data collected based on 22 patient reviews on Google

Certificates

Features & Facts

Next-Gen IO-VAC Vaccine

Every patient receives a bespoke IO-VAC vaccine. It combines the patient's own dendritic cells with tumor antigens and an oncolytic virus (NDV) to dismantle the "camouflage" of solid tumors.

Exclusive European License

IOZK is the only institute in Europe holding a manufacturing license (Section 13 AMG) to produce personalized anti-tumor vaccines from dendritic cells and oncolytic viruses in a GMP-certified lab.

Glioblastoma Survival Breakthrough

Clinical data show that combining standard care with IOZK immunotherapy can double the survival rate in patients with glioblastoma. Median overall survival for certain subgroups reached 33 months.

German Medical Award Winner

Founder Dr. Wilfried Stücker and the team received the German Medical Award (2020) for outstanding innovation in oncology, recognizing their high-quality, evidence-based approach to cancer.

Pioneering Multimodal Therapy

As the only clinic combining tumor vaccination with oncolytic virotherapy and hyperthermia, IOZK has treated 2,000+ patients, offering a potent fourth pillar alongside traditional surgery.

Liquid Biopsy Precision

Using advanced molecular genetics, the center monitors circulating tumor cells in the blood to adjust treatment in real-time. This "Smart Monitoring" ensures the vaccine matches the current tumor state.

Pediatric Neuro-Oncology Hub

IOZK specializes in high-grade gliomas and DIPG in children. Their new protocols offer a non-toxic alternative for pediatric patients, focusing on high tolerability and long-term immune memory.

About the clinic

The Immuno-Oncology Center Cologne (IOZK) is a world-class medical facility specializing in individualized cancer therapy by specifically activating the patient's own immune system. By operating as a translational center, IOZK ensures that the latest results of fundamental immunological research are directly applied to clinical practice. This interdisciplinary approach, led by a team of leading physicians and experienced scientists, allows the clinic to offer therapeutic options that complement and significantly enhance traditional tumor treatments such as surgery, radiation, and chemotherapy. Located in the heart of Cologne, the 2,300-square-meter facility is equipped with state-of-the-art laboratories and specialized treatment suites. The scientists at IOZK have been researching the immune system's role in cancer and chronic infections since 1985, leading to the development of the first autologous cancer vaccine in Europe to receive regulatory approval. This vaccine, known as IO-VAC®, is a personalized solution that combines the patient's own dendritic cells with tumor antigens and an oncolytic virus, effectively training the immune system to recognize and eliminate malignant cells. For this pioneering discovery, the center was honored with the German Medical Prize in 2020. The medical team at IOZK possesses exceptional expertise across internal medicine, oncology, pediatric hemato-oncology, and immunology. Unlike standard therapies that focus solely on the tumor, the IOZK protocol, known as individualized multimodal immunotherapy (IMI), integrates anti-tumor vaccination, oncolytic virotherapy, and hyperthermia. The clinic features five locoregional hyperthermia systems and three whole-body hyperthermia devices, which use electromagnetic fields or infrared radiation to weaken cancer cells and make them more susceptible to the immune response. This gentle, highly specific combination therapy is designed to maximize the patient's chances of survival while protecting their overall quality of life.

Primary focus

Departments & Doctors

Oncology, immunotherapy, cancer vaccines

Dr. med. Wilfried Stucker

oncology, personalized cancer vaccine, immunotherapy

Gallery

The role of the immune system in cancer

Cancer and mutations

Cancer and metastases

More about hyperthermia, part 2

More about hyperthermia, part 1

Immunotherapy in the context of naturopathy

Extra services

Visa Support

Telemedicine

Accessibility Features

Location

Hohenstaufenring 30-32, 50674 Köln, Germany

FAQ

What types of tumors can be treated in the Immuno-Oncological Center Cologne?

Oncologists use immunotherapy to treat malignant skin cancer, breast cancer, bile duct carcinoma, and brain tumors. Numerous studies have shown that therapy is effective and relatively well-tolerated across various tumor types. In addition, the technique extends the life span.

What are the patient benefits of immunotherapy compared to classical oncology?

Despite the latest surgery, chemotherapy, and radiation technologies, healthy body cells are still damaged. On the contrary, immunotherapy has a specific effect: only malignant cells are killed, with practically no side effects. Therefore, immuno-oncological treatment is the most gentle method.

When is the best time to administer IOZK immunotherapy?

IOZK therapy can be carried out at any time during tumor growth. However, recent data show that early-stage immunotherapy yields the best long-term results. Cancer vaccination and immunotherapy can also be combined with any conventional treatment.